Tom Godfrey
Stock Analyst at Ord Minnett
(4.81)
# 502
Out of 4,707 analysts
140
Total ratings
50.5%
Success rate
40.1%
Average return
Main Sectors:
Stocks Rated by Tom Godfrey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: EIQ Echo IQ Limited | Maintained: Buy | $2.00 → $1.55 | $0.65 | +138.46% | 9 | Sep 9, 2026 | |
| ASX: REG Regis Healthcare Limited | Downgraded: Hold | $8.40 → $6.00 | $4.60 | +30.43% | 31 | Sep 3, 2026 | |
| ASX: MVF Monash IVF Group Limited | Maintained: Buy | $0.85 | $0.82 | +4.29% | 12 | Sep 1, 2026 | |
| ASX: SIG Sigma Healthcare Limited | Maintained: Buy | $3.40 | $2.67 | +27.58% | 12 | Aug 28, 2026 | |
| ASX: TRJ Trajan Group Holdings Limited | Maintained: Buy | $0.90 → $0.60 | $0.16 | +275.00% | 7 | Aug 28, 2026 | |
| ASX: PGC Paragon Care Limited | Maintained: Buy | $0.33 → $0.30 | $0.14 | +118.98% | 9 | Aug 27, 2026 | |
| ASX: IDX Integral Diagnostics Limited | Maintained: Buy | $3.20 → $3.30 | $2.32 | +42.24% | 15 | Aug 26, 2026 | |
| NZE: EBO EBOS Group Limited | Maintained: Buy | $34.52 → $32.05 | $20.36 | +57.43% | 8 | Aug 20, 2026 | |
| ASX: ACL Australian Clinical Labs Limited | Maintained: Hold | $2.20 → $2.60 | $2.79 | -6.81% | 10 | Aug 18, 2026 | |
| ASX: VFY Vitrafy Life Sciences Limited | Maintained: Buy | $4.20 → $5.00 | $3.85 | +29.87% | 6 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $3.00 | $3.48 | -13.67% | 12 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $0.05 → $0.02 | $0.01 | +300.00% | 9 | May 12, 2026 |
Echo IQ Limited
Sep 9, 2026
Maintained: Buy
Price Target: $2.00 → $1.55
Current: $0.65
Upside: +138.46%
Regis Healthcare Limited
Sep 3, 2026
Downgraded: Hold
Price Target: $8.40 → $6.00
Current: $4.60
Upside: +30.43%
Monash IVF Group Limited
Sep 1, 2026
Maintained: Buy
Price Target: $0.85
Current: $0.82
Upside: +4.29%
Sigma Healthcare Limited
Aug 28, 2026
Maintained: Buy
Price Target: $3.40
Current: $2.67
Upside: +27.58%
Trajan Group Holdings Limited
Aug 28, 2026
Maintained: Buy
Price Target: $0.90 → $0.60
Current: $0.16
Upside: +275.00%
Paragon Care Limited
Aug 27, 2026
Maintained: Buy
Price Target: $0.33 → $0.30
Current: $0.14
Upside: +118.98%
Integral Diagnostics Limited
Aug 26, 2026
Maintained: Buy
Price Target: $3.20 → $3.30
Current: $2.32
Upside: +42.24%
EBOS Group Limited
Aug 20, 2026
Maintained: Buy
Price Target: $34.52 → $32.05
Current: $20.36
Upside: +57.43%
Australian Clinical Labs Limited
Aug 18, 2026
Maintained: Hold
Price Target: $2.20 → $2.60
Current: $2.79
Upside: -6.81%
Vitrafy Life Sciences Limited
Aug 14, 2026
Maintained: Buy
Price Target: $4.20 → $5.00
Current: $3.85
Upside: +29.87%
Jun 3, 2026
Maintained: Sell
Price Target: $3.00
Current: $3.48
Upside: -13.67%
May 12, 2026
Maintained: Buy
Price Target: $0.05 → $0.02
Current: $0.01
Upside: +300.00%